Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women

Long-term Prevention of Mortality in Morbid Obesity Through Bariatric Surgery. A Systematic Review and Meta-analysis of Trials Performed With Gastric Banding and Gastric Bypass

(2011) Antonio E. Pontiroli et al.   ANNALS OF SURGERY

Weight Loss after Gastric Bypass Surgery in Women Is Followed by a Metabolically Favorable Decrease in 11β-Hydroxysteroid Dehydrogenase 1 Expression in Subcutaneous Adipose Tissue

(2010) Kotryna Šimonytė et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Urinary Cortisol and Six-Year Risk of All-Cause and Cardiovascular Mortality

(2010) Nicole Vogelzangs et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Late-Life Depression, Cortisol, and the Metabolic Syndrome

(2009) Nicole Vogelzangs et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Lack of regulation of 11β-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism

(2009) Helga A Sigurjonsdottir et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Obesity Is Accompanied by Disturbances in Peripheral Glucocorticoid Metabolism and Changes in FA Recycling

(2009) Kotryna Simonyte et al.   Obesity

Enhanced cortisol production rates, free cortisol, and 11β-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss

(2008) Jonathan Q. Purnell et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Reduced Glucocorticoid Production Rate, Decreased 5 -Reductase Activity, and Adipose Tissue Insulin Sensitization After Weight Loss

(2008) J. W. Tomlinson et al.   DIABETES

Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5 -Reductase Activity

(2008) J. W. Tomlinson et al.   DIABETES